Bionano Genomics Inc. (BNGO) |
|
2.55 0.01 (0.39%)
|
01-16 05:45 |
|
Open: |
2.5164 |
Pre. Close: |
2.54 |
|
High:
|
2.615 |
Low:
|
2.4309 |
|
Volume:
|
6,797,509 |
Market Cap:
|
737M |
|
|
|
|
Bionano Genomics, Inc., a genome analysis company, provides tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing. Its Saphyr system is a research use only platform for ultra-sensitive and ultra-specific structural variation detection that enables scientists and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. The company also provides diagnostic testing for those with autism spectrum disorder and other neurodevelopmental disabilities. In addition, it offers an agnostic cross-platform data interpretation and clinical reporting software that integrates next-generation sequencing and microarray data, and provides visualization of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome for a fully integrated analysis in one view. The company was founded in 2006 and is headquartered in San Diego, California. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
2.622 - 2.634 |
2.634 - 2.646 |
|
Low:
|
2.4 - 2.413 |
2.413 - 2.426 |
|
Close:
|
2.527 - 2.549 |
2.549 - 2.57 |
|
Technical analysis |
as of: 2022-01-15 8:44:55 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 3.70  One year: 4.23 |
| Support: |
Support1: 2.43 Support2: 2.02 |
| Resistance: |
Resistance1: 3.17 Resistance2: 3.62 |
| Pivot: |
2.90 |
| Moving Average: |
MA(5): 2.66 MA(20): 2.99
MA(100): 4.56 MA(250): 6.38 |
| MACD: |
MACD(12,26): -0.30 Signal(9): -0.30 |
| Stochastic oscillator: |
%K(14,3): 11.62 %D(3): 14.09 |
| RSI: |
RSI(14): 29.50  |
| 52-week: |
High: 15.69 Low: 2.43 Change(%): -69.2 |
| Average Vol(K): |
3-Month: 921154 10-Days: 881062 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.BNGO has closed above bottom band by 12.9%. Bollinger Bands are 8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Thu, 13 Jan 2022
Bionano Genomics Hosts Final Day of 2022 Symposium with Presentations Demonstrating the Combined Detection Power of OGM and NGS - Yahoo Finance
Wed, 12 Jan 2022
Bionano Genomics Reports Preliminary Fourth Quarter and Full-Year 2021 Results - Yahoo Finance
Mon, 10 Jan 2022
Bionano Genomics Announces Publication Of Interim Readout From Consortium Conducting Postnatal Clinical Trial Intended To Support Establishing Optical Genome Mapping As Part Of Standard Of Care In Genetic Disease Diagnosis - Benzinga
Wed, 29 Dec 2021
Thinking about buying stock in TMC The Metals Company, Cal-Maine Foods, FuelCell Energy, Vaxart, or BioNano Genomics? - PRNewswire
Thu, 23 Dec 2021
University Hospitals Leuven in Belgium Outlines their Menu - GlobeNewswire
Wed, 22 Dec 2021
Bionano Genomics Appoints Vince Wong to its Board of Directors - GlobeNewswire
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Underperform |
| Return on Equity: |
Neutral |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Diagnostics & Research |
| Shares Out. (M) |
289 |
| Shares Float (M) |
283 |
|
% Held by Insiders
|
2.17 |
|
% Held by Institutions
|
25.64 |
|
Shares Short (K)
|
40,520 |
|
Shares Short P. Month (K)
|
40,170 |
Stock Financials |
|
EPS
|
-0.250 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
1.210 |
|
Profit Margin
|
|
|
Operating Margin
|
-369.80 |
|
Return on Assets (ttm)
|
-18.1 |
|
Return on Equity (ttm)
|
-34.4 |
|
Qtrly Rev. Growth
|
112.0 |
|
Gross Profit (p.s.)
|
0.010 |
|
Sales Per Share
|
0.054 |
|
EBITDA (p.s.)
|
-0.193 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-58 |
|
Levered Free Cash Flow (M)
|
-28 |
Stock Valuations |
|
PE Ratio
|
-10.20 |
|
PEG Ratio
|
|
|
Price to Book value
|
2.11 |
|
Price to Sales
|
47.06 |
|
Price to Cash Flow
|
-12.62 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
